Glycodeoxycholic Acid-d4 – 500 µg

Brand:
Cayman
CAS:
1069132-37-1
Storage:
-20
UN-No:
Non-Hazardous - /

Glycodeoxycholic acid-d4 is intended for use as an internal standard for the quantification of glycodeoxycholic acid (Item No. 20274) by GC- or LC-MS. Glycodeoxycholic acid (GDCA) is a glycine-conjugated form of the secondary bile acid deoxycholic acid (Item Nos. 18231 | 20756).{48223} It induces a reversible, concentration-dependent reduction in myogenic tone in rats and decreases expression of the gene encoding the cytochrome P450 (CYP) isoform 7A1 (CYP7A1) in rabbits.{33912,33913} Serum levels of GDCA are elevated in non-surviving patients with acetaminophen-induced acute liver failure (AALF) compared with survivors.{33914} GDCA levels are also increased in the plasma of patients with asthma.{33911}  

 

Available on backorder

SKU: 31310 - 500 µg Category:

Description

An internal standard for the quantification of glycodeoxycholic acid by GC- or LC-MS


Formal name: N-[(3α,5β,12α)-3,12-dihydroxy-24-oxocholan-24-yl-2,2,4,4-d4]-glycine

Synonyms:  GDCA-d4

Molecular weight: 453.7

CAS: 1069132-37-1

Purity: ≥99% deuterated forms (d1-d4)

Formulation: A solid